Literature DB >> 32610006

Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models.

Meagan E Deming1, Nelson L Michael1, Merlin Robb1, Myron S Cohen1, Kathleen M Neuzil1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32610006     DOI： 10.1056/NEJMp2020076

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

1.  Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.

Authors:  Jeffrey P Kahn; Leslie Meltzer Henry; Anna C Mastroianni; Wilbur H Chen; Ruth Macklin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-29       Impact factor: 11.205

2.  Nanoceutical Fabric Prevents COVID-19 Spread through Expelled Respiratory Droplets: A Combined Computational, Spectroscopic, and Antimicrobial Study.

Authors:  Aniruddha Adhikari; Uttam Pal; Sayan Bayan; Susmita Mondal; Ria Ghosh; Soumendra Darbar; Tanusri Saha-Dasgupta; Samit Kumar Ray; Samir Kumar Pal
Journal:  ACS Appl Bio Mater       Date:  2021-06-17

Review 3.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

4.  Research ethics and public trust in vaccines: the case of COVID-19 challenge trials.

Authors:  Nir Eyal
Journal:  J Med Ethics       Date:  2022-05-20       Impact factor: 5.926

Review 5.  A new day for human challenge trials?

Authors:  Abie Rohrig; Nir Eyal
Journal:  Trends Mol Med       Date:  2022-05-22       Impact factor: 15.272

Review 6.  Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities.

Authors:  Shelan Liu; Min Kang; Na Zhao; Yali Zhuang; Shijian Li; Tie Song
Journal:  Med Rev (Berl)       Date:  2022-05-25

7.  Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.

Authors:  Ben Killingley; Alex J Mann; Mariya Kalinova; Alison Boyers; Niluka Goonawardane; Jie Zhou; Kate Lindsell; Samanjit S Hare; Jonathan Brown; Rebecca Frise; Emma Smith; Claire Hopkins; Nicolas Noulin; Brandon Löndt; Tom Wilkinson; Stephen Harden; Helen McShane; Mark Baillet; Anthony Gilbert; Michael Jacobs; Christine Charman; Priya Mande; Jonathan S Nguyen-Van-Tam; Malcolm G Semple; Robert C Read; Neil M Ferguson; Peter J Openshaw; Garth Rapeport; Wendy S Barclay; Andrew P Catchpole; Christopher Chiu
Journal:  Nat Med       Date:  2022-03-31       Impact factor: 87.241

8.  COVIDScreen: explainable deep learning framework for differential diagnosis of COVID-19 using chest X-rays.

Authors:  Rajeev Kumar Singh; Rohan Pandey; Rishie Nandhan Babu
Journal:  Neural Comput Appl       Date:  2021-01-08       Impact factor: 5.606

Review 9.  So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.

Authors:  Christine Grady; Seema Shah; Franklin Miller; Marion Danis; Marie Nicolini; Jorge Ochoa; Holly Taylor; Dave Wendler; Annette Rid
Journal:  Vaccine       Date:  2020-08-11       Impact factor: 3.641

10.  Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19.

Authors:  Maria Laura De Angelis; Federica Francescangeli; Rachele Rossi; Alessandro Giuliani; Ruggero De Maria; Ann Zeuner
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.